Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature Precedings
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • RSS feed
  1. nature
  2. nature precedings
  3. articles
  4. article
A Targeted Therapeutic Rescues Botulinum Toxin-A Poisoned Neurons
Download PDF
Download PDF
  • Manuscript
  • Open access
  • Published: 13 August 2008

A Targeted Therapeutic Rescues Botulinum Toxin-A Poisoned Neurons

  • Prabhati Ray1,
  • Bal Ram Singh2,
  • Radharaman Ray3,
  • Peng Zhang1,
  • Dan Li4,
  • James Keller5 &
  • …
  • Michael Adler3 

Nature Precedings (2008)Cite this article

  • 568 Accesses

  • 2 Citations

  • Metrics details

Abstract

Botulinum neurotoxin (BoNT), a Category A biothreat agent, is the most potent poison known to mankind. Currently no antidote is available to rescue poisoned synapses. BoNT acts specifically by blocking neurotransmission primarily at peripheral nerve-muscle junctions causing severe flaccid muscle paralysis, which is fatal if proper medical care is not provided. The neurotoxin acts by specifically entering the presynaptic nerve endings where it interferes with the biochemical machinery involved in the process of neurotransmitter release, i.e., neuroexocytosis. Most serotypes of BoNT are known to remain active for weeks to months after entering the nerves, but BoNT/A is the most potent and long lasting in causing muscle paralysis. An effective medical countermeasure strategy requires developing a drug that could rescue poisoned neuromuscular synapses, and would include its efficient delivery specifically to presynaptic nerve terminals. Here we report rescuing of botulinum poisoned nerve cells by Mastoparan-7 (Mas-7), a peptide constituent of bee venom, that was delivered through a drug delivery vehicle (DDV) constructed from the non-toxic fragment of botulinum neurotoxin itself. We found that Mas-7 that was delivered into BoNT/A intoxicated cultured mouse spinal cord cells restored over 40% of stimulated neurotransmitter release. The rescue of the cell poisoning did not occur from inhibition of the endopeptidase activity of BoNT/A against its well known substrate, SNAP-25 that is mechanistically involved in the exocytosis process. Rather, Mas-7 induced a physiological host response apparently unrelated to SNAP-25, but linked to the phospholipase signal transduction pathway. In addition to providing the first effective antidote against botulism, our results open new avenues to study the mechanism of exocytosis, and also to examine an alternative cellular mechanism of botulinum neurotoxin action. An effective BoNT-based DDV can also be utilized for drug delivery against many neuronal and neuromuscular disorders.

Similar content being viewed by others

Botulinum neurotoxin A mutants with enhanced ganglioside binding show improved potency and altered ganglioside selectivity

Article Open access 04 June 2025

Split luciferase-based assay to detect botulinum neurotoxins using hiPSC-derived motor neurons

Article Open access 30 January 2023

Botulinum neurotoxin A ameliorates depressive-like behavior in a reserpine-induced Parkinson’s disease mouse model via suppressing hippocampal microglial engulfment and neuroinflammation

Article Open access 10 February 2023

Article PDF

Author information

Authors and Affiliations

  1. Walter Reed Army Institute of Research, Experimental Therapeutics https://www.nature.com/nature

    Prabhati Ray & Peng Zhang

  2. University of Massachusetts, Department of Chemistry and Biochemistry https://www.nature.com/nature

    Bal Ram Singh

  3. United States Army Medical Research Institute of Chemical Defense https://www.nature.com/nature

    Radharaman Ray & Michael Adler

  4. Walter Reed Army Institute of Research https://www.nature.com/nature

    Dan Li

  5. U. S. Food and Drug Administration https://www.nature.com/nature

    James Keller

Authors
  1. Prabhati Ray
    View author publications

    Search author on:PubMed Google Scholar

  2. Bal Ram Singh
    View author publications

    Search author on:PubMed Google Scholar

  3. Radharaman Ray
    View author publications

    Search author on:PubMed Google Scholar

  4. Peng Zhang
    View author publications

    Search author on:PubMed Google Scholar

  5. Dan Li
    View author publications

    Search author on:PubMed Google Scholar

  6. James Keller
    View author publications

    Search author on:PubMed Google Scholar

  7. Michael Adler
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Creative Commons Attribution 3.0 License.

Reprints and permissions

About this article

Cite this article

Ray, P., Singh, B., Ray, R. et al. A Targeted Therapeutic Rescues Botulinum Toxin-A Poisoned Neurons. Nat Prec (2008). https://doi.org/10.1038/npre.2008.2149.1

Download citation

  • Received: 01 August 2008

  • Accepted: 13 August 2008

  • Published: 13 August 2008

  • DOI: https://doi.org/10.1038/npre.2008.2149.1

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • BoNT
  • DDV
  • mastoparen
  • Targeted Therapeutic
  • drug delivery
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Nature Precedings (Nat Preced)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing